PPP1R14A and cancer: Meanwhile, our analysis, broadly explains the PPP1R14A promoter methylation level is significantly altered in BLCA, COAD, KIRP, and other cancers, giving clarity and expectation that the PPP1R14A could become a novel prognostic marker and potential therapeutic target.